Compare BLCO & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | MNSO |
|---|---|---|
| Founded | 1853 | 2013 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.0B |
| IPO Year | 2022 | 2020 |
| Metric | BLCO | MNSO |
|---|---|---|
| Price | $17.44 | $19.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | $17.31 | ★ $24.10 |
| AVG Volume (30 Days) | 360.9K | ★ 540.3K |
| Earning Date | 02-18-2026 | 11-20-2025 |
| Dividend Yield | N/A | ★ 3.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | ★ $4,976,000,000.00 | $2,795,603,723.00 |
| Revenue This Year | $8.06 | $27.54 |
| Revenue Next Year | $5.79 | $19.30 |
| P/E Ratio | ★ N/A | $20.21 |
| Revenue Growth | 6.23 | ★ 23.44 |
| 52 Week Low | $10.45 | $13.95 |
| 52 Week High | $18.34 | $26.74 |
| Indicator | BLCO | MNSO |
|---|---|---|
| Relative Strength Index (RSI) | 62.34 | 47.32 |
| Support Level | $16.22 | $19.12 |
| Resistance Level | $17.26 | $19.86 |
| Average True Range (ATR) | 0.34 | 0.34 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 91.73 | 53.13 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.